Evidence map›Paper›PMID 28747991›Full record

ArticleImmunome research2011

A computational pipeline to generate MHC binding motifs.

Peng Wang, John Sidney, Alessandro Sette, Bjoern Peters

Abstract read
In one paragraph

Article in Immunome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Advances in T-cell epitope engineering.Frontiers in immunology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peng WangLa Jolla Institute for Allergy & Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
John SidneyLa Jolla Institute for Allergy & Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Alessandro SetteLa Jolla Institute for Allergy & Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Bjoern PetersLa Jolla Institute for Allergy & Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.

Funding

Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
NIAID NIH HHS HHSH266200400006CNIAID NIH HHS U19 AI100275
6 · The paper itself

Abstract

backgroundMajor histocompatibility complex (MHC) class I molecules play key roles in host immunity against pathogens by presenting peptide antigens to CD8+ T-cells. Many variants of MHC molecules exist, and each has a unique preference for certain peptide ligands. Both experimental approaches and computational algorithms have been utilized to analyze these peptide MHC binding characteristics. Traditionally, MHC binding specificities have been described in terms of binding motifs. Such motifs classify certain peptide positions as primary and secondary anchors according to their impact on binding, and they list the preferred and deleterious residues at these positions. This provides a concise and easily communicatable summary of MHC binding specificities. However, so far there has been no algorithm to generate such binding motifs in an automated and uniform fashion.

resultsIn this paper, we present a computational pipeline that takes peptide MHC binding data as input and produces a concise MHC binding motif. We tested our pipeline on a set of 18 MHC class I molecules and showed that the derived motifs are consistent with historic expert assignments.

conclusionsWe have implemented a pipeline that formally codifies rules to generate MHC binding motifs. The pipeline has been incorporated into the immune epitope database and analysis resource (IEDB) and motifs can be visualized while browsing MHC alleles in the IEDB.

Identifiers

PMID28747991
PMCPMC5524134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.